Proteolix Nets $45M
Proteolix, a San Francisco based biotech company, has raised $45M in a second round of funding. This brings their total amount received to $63M. Delphi Ventures led the round along with previous investors U.S. Venture Partners, Advanced Technology Partners, Latterell Venture Partners and The Vertical Group. Proteolix focuses on the treatment of cancer, inflammatory disease and autoimmunity.
posted on Thursday, June 1, 2006 (Link to more information)
Related companies:
Proteolix
Related stories:
> Onyx Pharmaceuticals Acquires Proteolix
> Proteolix Takes $79M In Third Round
> hi5 Nets $20M
> PacketExchange Nets $12M
> Ning Nets $44M
silicontap.com Home